Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

CompletedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

January 20, 2016

Primary Completion Date

March 7, 2018

Study Completion Date

March 7, 2018

Conditions
Chronic Hepatitis C
Trial Locations (9)

3318 AT

Albert Schweitzer Ziekenhuis /ID# 152597, Dordrecht

1815 JD

Noordwest Ziekenhuisgroep /ID# 152604, Alkmaar

1061 AE

Duplicate_Onze Lieve Vrouwe Gasthuis /ID# 152600, Amsterdam

9713 GZ

Universitair Medisch Centrum Groningen /ID# 152596, Groningen

2333 ZA

Leids Universitair Medisch Centrum /ID# 154637, Leiden

6526 GA

Radbound University Medical Ce /ID# 152598, Nijmegen

3015 CE

Erasmus Medisch Centrum /ID# 154635, Rotterdam

3079 DZ

Maasstad Ziekenhuis /ID# 152592, Rotterdam

3584 CX

Universitair Medisch Centrum Utrecht /ID# 152595, Utrecht

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY